Repression of Sestrin Family Genes Contributes to Oncogenic Ras-Induced ROS Up-Regulation and Genetic Instability

Oncogenic mutations within RAS genes and inactivation of p53 are the most common events in cancer. Earlier we reported that activated Ras contributes to chromosome instability, especially in p53-deficient cells. Here we show that an increase in intracellular reactive oxygen species (ROS) and oxidati...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 67; no. 10; pp. 4671 - 4678
Main Authors Kopnin, Pavel B., Agapova, Larissa S., Kopnin, Boris P., Chumakov, Peter M.
Format Journal Article
LanguageEnglish
Published 15.05.2007
Online AccessGet full text

Cover

Loading…
Abstract Oncogenic mutations within RAS genes and inactivation of p53 are the most common events in cancer. Earlier we reported that activated Ras contributes to chromosome instability, especially in p53-deficient cells. Here we show that an increase in intracellular reactive oxygen species (ROS) and oxidative DNA damage represents a major mechanism of Ras-induced mutagenesis. Introduction of oncogenic H- or N-Ras caused elevated intracellular ROS, accumulation of 8-oxo-dG and increased number of chromosome breaks in mitotic cells, which were prevented by antioxidant N-acethyl-L-cysteine (NAC). By using Ras mutants that selectively activate either of the three major targets of Ras (Raf, RalGDS and PI3K) as well as dominant-negative Rac1 and RalA mutants and inhibitors of MEK1 and p38 MAPKs we have demonstrated that several Ras effectors independently mediate ROS up-regulation. Introduction of oncogenic RAS resulted in repression of transcription from sestrin family genes SESN1 and SESN3 , which encode antioxidant modulators of peroxiredoxins. Inhibition of mRNAs from these genes in control cells by RNAi increased substantially ROS levels and mutagenesis. Ectopic expression of SESN1 and SESN3 from lentiviral constructs interfered with Ras-induced ROS increase suggesting their important contribution to the effect. The stability of Ras-induced increase in ROS was dependent on a p53 function: in the p53-positive cells displaying activation of p53 in response to Ras only transient (4–7 days) elevation of ROS was observed whereas in the p53-deficient cells the up-regulation was permanent. The reversion to normal ROS levels in the Ras-expressing p53-positive cells correlated with up-regulation of p53-responsive genes, including reactivation of SESN1 gene. Thus, changes in expression of sestrins can represent important determinant of genetic instability in neoplastic cells showing simultaneous dysfunctions of Ras and p53.
AbstractList Oncogenic mutations within RAS genes and inactivation of p53 are the most common events in cancer. Earlier we reported that activated Ras contributes to chromosome instability, especially in p53-deficient cells. Here we show that an increase in intracellular reactive oxygen species (ROS) and oxidative DNA damage represents a major mechanism of Ras-induced mutagenesis. Introduction of oncogenic H- or N-Ras caused elevated intracellular ROS, accumulation of 8-oxo-dG and increased number of chromosome breaks in mitotic cells, which were prevented by antioxidant N-acethyl-L-cysteine (NAC). By using Ras mutants that selectively activate either of the three major targets of Ras (Raf, RalGDS and PI3K) as well as dominant-negative Rac1 and RalA mutants and inhibitors of MEK1 and p38 MAPKs we have demonstrated that several Ras effectors independently mediate ROS up-regulation. Introduction of oncogenic RAS resulted in repression of transcription from sestrin family genes SESN1 and SESN3 , which encode antioxidant modulators of peroxiredoxins. Inhibition of mRNAs from these genes in control cells by RNAi increased substantially ROS levels and mutagenesis. Ectopic expression of SESN1 and SESN3 from lentiviral constructs interfered with Ras-induced ROS increase suggesting their important contribution to the effect. The stability of Ras-induced increase in ROS was dependent on a p53 function: in the p53-positive cells displaying activation of p53 in response to Ras only transient (4–7 days) elevation of ROS was observed whereas in the p53-deficient cells the up-regulation was permanent. The reversion to normal ROS levels in the Ras-expressing p53-positive cells correlated with up-regulation of p53-responsive genes, including reactivation of SESN1 gene. Thus, changes in expression of sestrins can represent important determinant of genetic instability in neoplastic cells showing simultaneous dysfunctions of Ras and p53.
Author Kopnin, Pavel B.
Kopnin, Boris P.
Agapova, Larissa S.
Chumakov, Peter M.
AuthorAffiliation 1 Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia
2 University of Oslo, Centre for Medical Studies in Russia, 119334 Moscow, Russia
3 Institute of Carcinogenesis, Russian Blokhin Cancer Research Center, Moscow, Russia
4 Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA
AuthorAffiliation_xml – name: 2 University of Oslo, Centre for Medical Studies in Russia, 119334 Moscow, Russia
– name: 4 Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA
– name: 3 Institute of Carcinogenesis, Russian Blokhin Cancer Research Center, Moscow, Russia
– name: 1 Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia
Author_xml – sequence: 1
  givenname: Pavel B.
  surname: Kopnin
  fullname: Kopnin, Pavel B.
  organization: Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia University of Oslo, Centre for Medical Studies in Russia, 119334 Moscow, Russia Institute of Carcinogenesis, Russian Blokhin Cancer Research Center, Moscow, Russia Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA
– sequence: 2
  givenname: Larissa S.
  surname: Agapova
  fullname: Agapova, Larissa S.
  organization: Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia University of Oslo, Centre for Medical Studies in Russia, 119334 Moscow, Russia Institute of Carcinogenesis, Russian Blokhin Cancer Research Center, Moscow, Russia Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA
– sequence: 3
  givenname: Boris P.
  surname: Kopnin
  fullname: Kopnin, Boris P.
  organization: Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia University of Oslo, Centre for Medical Studies in Russia, 119334 Moscow, Russia Institute of Carcinogenesis, Russian Blokhin Cancer Research Center, Moscow, Russia Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA
– sequence: 4
  givenname: Peter M.
  surname: Chumakov
  fullname: Chumakov, Peter M.
  organization: Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia University of Oslo, Centre for Medical Studies in Russia, 119334 Moscow, Russia Institute of Carcinogenesis, Russian Blokhin Cancer Research Center, Moscow, Russia Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA
BookMark eNqljd1KwzAUx4NMXKc-gpAXyEzapq03ghSnu9mgm9clbc9qpD2pTSr07Y0igtdenf8Xv7MiCzQIhNwIvhZCZrec84zJOA3X-cOO8YSFcZKckUDIKGNpHMsFCX43S7Ky9s1bKbi8IEuRehHdRQF5L2AYwVptkJoTPYB1o0a6Ub3uZvoECJbmBn1YTc5rZ-gea9MC6poWyrItNlMNDS32B_oysALaqVPuC6ew-QY4v9yidarSnXbzFTk_qc7C9c-9JPebx2P-zIap6qGpwT9TXTmMulfjXBqly78N6teyNR9lmMhUyij6N-ATiyxspQ
ContentType Journal Article
DBID 5PM
DOI 10.1158/0008-5472.CAN-06-2466
DatabaseName PubMed Central (Full Participant titles)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 4678
GroupedDBID ---
-ET
.55
18M
29B
2WC
34G
39C
3O-
476
53G
5GY
5PM
5RE
5VS
6J9
8WZ
A6W
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
AENEX
AETEA
AFFNX
AFHIN
AFOSN
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
C1A
CS3
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
MVM
OHT
OK1
P0W
P2P
PQQKQ
RCR
RHF
RHI
RNS
SJN
TR2
UDS
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
XJT
YKV
YZZ
ZCG
ZGI
ID FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_26575533
ISSN 0008-5472
IngestDate Tue Sep 17 21:08:37 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-pubmedcentral_primary_oai_pubmedcentral_nih_gov_26575533
Notes Senior authors contributed equally to the work
PMID 17510393
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2657553
PublicationCentury 2000
PublicationDate 20070515
PublicationDateYYYYMMDD 2007-05-15
PublicationDate_xml – month: 5
  year: 2007
  text: 20070515
  day: 15
PublicationDecade 2000
PublicationTitle Cancer research (Chicago, Ill.)
PublicationYear 2007
SSID ssj0005105
Score 3.7665517
Snippet Oncogenic mutations within RAS genes and inactivation of p53 are the most common events in cancer. Earlier we reported that activated Ras contributes to...
SourceID pubmedcentral
SourceType Open Access Repository
StartPage 4671
Title Repression of Sestrin Family Genes Contributes to Oncogenic Ras-Induced ROS Up-Regulation and Genetic Instability
URI https://pubmed.ncbi.nlm.nih.gov/PMC2657553
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUKSIgLYhW7fOAWJZBmKxckCCAWFaoWJG7IKSkgShKg9MC38XHMeJzEgR6gF6uNFdvKPI3H9vMbxrZR1G0v8rpmYIsYt248M7qHwodYXwR7vu3LPGTNS__0xj2_9W5rtS-NtfQxiKzu58h7JeNYFZ6BXfGW7D8sWzQKD-A32BdKsDCUf7JxO6exypivE2MOjiTPZYGC0jIhJ-W0IimHq6SbQnPInhfvJubtwPP_9lXHuMnMNuWlzwnK2ADKuSKfgNS8K0fAIeLlzVBqQY_yOJh4HdLv9PuWtstwkWYJqRW0xDDuG4dWgbQHkaVDQXe0weO8C6Nj_X7tMIU6o1XUhJhc8DkdFhxjo2lVdjACPHynO5yFV26YnkspfKy4dMSBS1KTuaemxB05Inc1vwvu3tbmcPjbGD0_eA0iVFKHVnhwibyvukupXzTMZC8SNBBd4WG5U06XOUWg1QzreGrlORNsqg4gx6X_0dlFSTBSBNq8M3V_DIawM3IAqF-revvJ0NVCnus5NqvWKvyAgDfPanGywKabio2xyF5L_PG0xxX-OOGPS_xxDX98kPICf1zDHwf88Qr-OOCPK_xxDX9LbP_k-Do8NSvjvstIMuUORcyrNcnToxQzV9_QWWaTSZrEK4zHPbseia4DLsR3bYiXIKaMbNHzYeXrNO7tVRaM2cna2G-us5kSuRtscvD2EW9CNDqItqTRvwGYRJCM
link.rule.ids 230,315,786,790,891,27957,27958
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Repression+of+Sestrin+Family+Genes+Contributes+to+Oncogenic+Ras-Induced+ROS+Up-Regulation+and+Genetic+Instability&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Kopnin%2C+Pavel+B.&rft.au=Agapova%2C+Larissa+S.&rft.au=Kopnin%2C+Boris+P.&rft.au=Chumakov%2C+Peter+M.&rft.date=2007-05-15&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=67&rft.issue=10&rft.spage=4671&rft.epage=4678&rft_id=info:doi/10.1158%2F0008-5472.CAN-06-2466&rft_id=info%3Apmid%2F17510393&rft.externalDBID=PMC2657553
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon